Debate over PMDD intensified in 2000, when the Food and Drug Administration approved the rebranding of the selective serotonin reuptake inhibitor (SSRI) fluoxetine under the marketing name Sarafem
to treat PMDD.
Lilly's fluoxetine (Prozac) was approved under the trade name Sarafem
for premenstrual dysphoric disorder in 2000, Pfizer's sertraline (Zoloft) added the PMDD claim in 2001, and GlaxoSmithKline's paroxetine (Paxil CR) followed in 2003.
Davi Johnson (2004) similarly found that advertisements for Sarafem
, a psychiatric medication for treating premenstrual dysphoric disorder (PMDD), are designed to simulate an intimate interpersonal encounter when featuring testimonials from a variety of women (p.
8 billion in sales in 2008) may not yet be the household names that Prozac, Ritalin, Paxil, Zoloft and Sarafem
are, but still are mega-blockbusters, a blockbuster being the code word for a drug that pulls in more than a billion in sales.
Brittany took (painkiller) Vicoprofen and (PMT drug) Sarafem
five days a week before her period.
Some of products expected to come off patent in 2008 include Sarafem
for premenstrual dysphoric disorder, Depakote for seizures, Cipro HC for external ear infections, and Dovonex for psoriasis.
The two drugs are identical, save that Sarafem
is coated pink instead of green.
Eli Lilly, after losing its Prozac patent, introduced an exact copy with a new color and called it Sarafem
For PMDD, women take Sarafem
during the two weeks before their menses--"a new concept, a mental illness that comes and goes every two weeks or so
The rights to Sarafem
have since been sold to another pharmaceutical company.
as well as combination hormone therapy treatment femhrt and Sarafem
, a treatment for severe pre-menstrual syndrome.
The group counts contraceptives Ovcon and Estrostep among its brands as well as combination hormone therapy treatment femhrt and Sarafem